Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-12 4:31 pm Sale |
2023-01-11 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 0 0.000% |
-2,436,732 (Position Closed) |
Filing History |
| 2022-04-01 5:18 pm Sale |
2022-03-30 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 2,436,732 7.200% |
-938,305 (-27.80%) |
Filing History |
| 2022-01-12 4:30 pm Sale |
2022-01-10 | 13D | ESSA Pharma Inc. EPIX |
Clarus Lifesciences III L.P. | 2,187,912 4.960% |
-1,291,202 (-37.11%) |
Filing History |
| 2021-07-30 4:32 pm Purchase |
2021-07-20 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 3,375,037 10.500% |
3,375,037 (New Position) |
Filing History |
| 2020-07-09 4:48 pm Sale |
2020-07-02 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,339,836 4.900% |
-283,569 (-17.47%) |
Filing History |
| 2020-05-01 5:01 pm Unchanged |
2019-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,623,405 11.100% |
0 (Unchanged) |
Filing History |